Bottom line
IBRN vs SBIO: the short answer
IBRN (iShares Neuroscience and Healthcare ETF) and SBIO (ALPS Medical Breakthroughs ETF) are quite different portfolios: only about 24% of their top holdings (by weight) are shared.
IBRN is cheaper at 0.47% vs 0.5% — a difference of $3.00 a year per $10,000 invested.
Over one year, SBIO returned +54.2% vs −2.7% for IBRN (reporting dates differ).
Updated Nov 19, 2026
IBRN vs SBIO side by side
| IBRN | SBIO | |
|---|---|---|
| Type | ETF | ETF |
| Fund family | iShares | Alps |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 0.47% | 0.5% |
| Annual cost per $10k | $47 | $50 |
| 10-yr cost on $10k (prospectus) | $591 | $628 |
| Max front load | None | None |
| 12b-1 fee | 0% | — |
| 1-yr return | −2.7% | +54.2% |
| 5-yr return (annualized) | — | +0.7% |
| 10-yr return (annualized) | — | +5.7% |
| Best quarter | +25.0% | +33.9% |
| Worst quarter | −13.5% | −30.8% |
| Net assets (fund) | $5.5M | $161.8M |
| Number of holdings | 78 | 89 |
| Portfolio turnover | 52% | 58% |
| Returns as of | Dec 31, 2024 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | IBRN | SBIO | Difference |
|---|---|---|---|
| 2024 | −2.7% | +4.2% | −6.8% |
| 2023 | +1.0% | +8.2% | −7.2% |
Source: Fund prospectus bar charts
Holdings overlap
6 of IBRN's top 25 holdings also appear in SBIO's top 25.
| Holding | IBRN | SBIO |
|---|---|---|
| Dianthus Therapeutics Inc | 5.34% | 2.64% |
| Xenon Pharmaceuticals Inc | 4.87% | 2.90% |
| Acadia Pharmaceuticals Inc. | 4.69% | 2.35% |
| Alkermes Public Limited Company | 4.60% | 4.48% |
| Denali Therapeutics Inc | 3.67% | 2.13% |
| Edgewise Therapeutics Inc | 3.23% | 2.33% |
Source: SEC Form N-PORT
IBRN top 10
- BlackRock Funds III: BlackRock Cash Funds: Institutional; SL Agency Shares — 14.64%
- Dianthus Therapeutics Inc — 5.34%
- Xenon Pharmaceuticals Inc — 4.87%
- Praxis Precision Medicines Inc — 4.87%
- Acadia Pharmaceuticals Inc. — 4.69%
- Arrowhead Pharmaceuticals, Inc. — 4.65%
- Alkermes Public Limited Company — 4.60%
- Scholar Rock Holding Corp — 4.29%
- Biogen Inc. — 4.18%
- Neurocrine Biosciences, Inc. — 4.09%
SBIO top 10
- Alkermes Plc — 4.48%
- Kymera Therapeutics Inc — 4.23%
- Celcuity Inc — 3.92%
- Mirum Pharmaceuticals Inc — 3.90%
- Spyre Therapeutics Inc — 3.68%
- Cg Oncology Inc — 3.35%
- Apogee Therapeutics Inc — 2.93%
- Xenon Pharmaceuticals Inc — 2.90%
- Travere Therapeutics Inc — 2.77%
- Dianthus Therapeutics Inc — 2.64%
FAQ
What is the difference between IBRN and SBIO?
Which is cheaper, IBRN or SBIO?
Should I own both IBRN and SBIO?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.